NovoCure Surges 6.4% on Strong 2025 Results and Optune Pax Approval, Bucking Bearish Trend

🟢 NovoCure Surges 6.4% on Strong 2025 Results and Optune Pax Approval, Bucking Bearish Trend | MarketDownload | MarketDownload